Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907866 · ClinicalTrials.gov registry record
Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 17
- Enrollment target
NCT02907866 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 17 participants.
The verdict
NCT02907866 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
Endobronchial ultrasound (EBUS) is a technique that uses ultrasound along with bronchoscope to visualize airway wall and structures adjacent to it. Pneumothorax is a known complication from EBUS procedure. To rule out a Pneumothorax after the procedure, a Chest -X-ray is usually done. Point-of-care sonography has emerged as an invaluable tool in the assessment of patients with both traumatic and non-traumatic dyspnea. Multiple studies involving bedside ultrasound has shown that a pneumothorax can easily be ruled out if pleural sliding sign or B lines are visualized on lung ultrasonography; the accuracy of lung ultrasound in ruling out pneumothorax approach computed tomography and exceed plain radiography. Preforming a lung ultrasound using the EBUS bronchoscope tip as a way to rule out pneumothorax has never been described previously. If this is possible it will obviate the need of getting a Chest -X-ray and decrease the dose of radiation that the patient is exposed to. In this study we will demonstrate that the feasibility of using the transducer of the EBUS Bronchoscope to perform bedside lung ultrasound to rule out pneumothorax.
Interventions
- DEVICE Ultrasound with EBUS scope and with linear ultrasound probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2016-09 |
| Est. Completion | 2024-02-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907866
The ClinicalTrials.gov registry entry for NCT02907866 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound with EBUS scope and with linear ultrasound probe is the first listed.
NCT02907866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02907866 about?
NCT02907866 is a clinical study titled "Use of Endobronchial Ultrasound Scope (EBUS) Transducer to Identify Pneumothorax-A Feasibility Study". Endobronchial ultrasound (EBUS) is a technique that uses ultrasound along with bronchoscope to visualize airway wall and structures adjacent to it. Pneumothorax is a known complication from EBUS procedure. To rule out a Pneumothorax after the procedure, a Chest -X-ray is usually done. Point-of-care ...
What is the current status of trial NCT02907866?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2016-09. Estimated completion is 2024-02-09.
What interventions are being tested in trial NCT02907866?
The interventions under investigation include: Ultrasound with EBUS scope and with linear ultrasound probe (DEVICE).
Who is sponsoring clinical trial NCT02907866?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.